<- Go Home

Australian Clinical Labs Limited

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Market Cap

AUD 376.6M

Volume

853.4K

Cash and Equivalents

AUD 22.4M

EBITDA

AUD 81.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

AUD 270.2M

Profit Margin

36.63%

52 Week High

AUD 3.03

52 Week Low

AUD 1.83

Dividend

6.19%

Price / Book Value

2.57

Price / Earnings

14.33

Price / Tangible Book Value

-26.60

Enterprise Value

AUD 669.1M

Enterprise Value / EBITDA

3.29

Operating Income

AUD 68.6M

Return on Equity

16.68%

Return on Assets

7.48

Cash and Short Term Investments

AUD 23.1M

Debt

AUD 315.1M

Equity

AUD 151.0M

Revenue

AUD 737.5M

Unlevered FCF

AUD 177.1M

Sector

Health Care Providers and Services

Category

N/A

Company Stock Pitches